TY  - BOOK
AU  - Bui, Anh B
AU  - Chen, Fang
AU  - Kardenas, Karina
AU  - Kitabata, Hironori
AU  - Magalhaes, Marco A
AU  - Ota, Hideaki
AU  - Pichard, Augusto D
AU  - Satler, Lowell F
AU  - Thomas, Caitlin H
AU  - Torguson, Rebecca
AU  - Waksman, Ron
TI  - Comparison of frequency and severity of longitudinal stent deformation among various drug-eluting stents: an intravascular ultrasound study
SN  - 0167-5273
KW  - *Coronary Artery Disease/us [Ultrasonography]
KW  - *Drug-Eluting Stents/ae [Adverse Effects]
KW  - *Equipment Failure
KW  - *Ultrasonography, Interventional/mt [Methods]
KW  - Aged
KW  - Cohort Studies
KW  - Coronary Artery Disease/th [Therapy]
KW  - Drug-Eluting Stents/st [Standards]
KW  - Female
KW  - Humans
KW  - Longitudinal Studies
KW  - Male
KW  - Middle Aged
KW  - Registries
KW  - Retrospective Studies
KW  - Treatment Outcome
KW  - MedStar Heart & Vascular Institute
N2  - BACKGROUND: Longitudinal stent deformation (LSD) in drug-eluting stents (DES) has been described as a disruption of stent structure. This study aimed to compare first- versus second-generation DES with respect to their actual stent length post deployment; CONCLUSION: This IVUS analysis confirms that among second-generation DES, there is overall similar frequency and severity of LSD when deploying in common coronary lesions.Copyright © 2014 Elsevier Ireland Ltd. All rights reserved; METHODS: A total of 617 DES for de novo coronary lesions in 552 patients were analyzed. Intravascular ultrasound (IVUS) was utilized to compare the degree and rate of LSD among six different DES types. IVUS-measured stent length was compared to the labeled length for calculation of absolute difference in stent length and relative absolute difference (absolute difference divided by the labeled length); RESULTS: The baseline characteristics were comparable between groups, except for higher calcification in the sirolimus-eluting stent (SES) group (p=0.037). The absolute and relative difference in length showed the lowest degree in the SES group and the highest degree in the Endeavor zotarolimus-eluting stent group (p=0.085 and 0.078, respectively). The percentage of more than 5% relative absolute difference was the lowest in the SES group compared to the other groups (p=0.018). However, the percentage of significant (>15%) relative absolute difference was similar among groups (p=0.99). In multivariate linear regression analysis, labeled stent length and stent diameter, but not stent type, were identified as independent correlates to the absolute and relative difference in the actual stent length post-deployment
UR  - http://dx.doi.org/10.1016/j.ijcard.2014.05.015
ER  -